Microfluidics, the science that deals with the behavior, precise control and manipulation of fluids that are geometrically constrained to a small, typically sub-millimeter scale, emerged in the beginning of the 1980s and is used widely in technologies such as inkjet print heads, DNA chips, lab-on-a-chip technology, micro-propulsion and micro-thermal technologies. GnuBIO has adapted technology developed in Dr. David Weitz laboratory at Harvard. This technology is combined with proprietary molecular biology assays to create a unique next-generation DNA sequencing technology. The science behind this GnuBIO sequencing technology utilizes droplet microfluidics to perform the biochemical reactions for sequencing inside of tiny picoliter -sized aqueous drops. Each droplet acts as a discrete reaction vessel, like a miniature test tube, where the sequencing assay is performed.

GnuBIO’s advantage over existing technologies in both time and cost is empowered by droplet microfluidics. Droplet microfluidics enables users to perform many millions of reactions per hour in small volumes providing both scale and flexibility.